Výsledky vyhledávání - "CISPLATIN

BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombination

Autor: Christopher Parker, Adam C. Chambers, Dustin J. Flanagan, Jasmine Wing Yu Ho, Tracey J. Collard, Greg Ngo, Duncan M. Baird, Penny Timms, Rhys G. Morgan, Owen J. Sansom, Ann C. Williams

Publikováno v: Parker, C, Chambers, A C, Flanagan, D J, Ho, J W Y, Collard, T J, Ngo, G, Baird, D M, Timms, P, Morgan, R G, Sansom, O J & Williams, A C 2022, ' BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombination ', DNA repair, vol. 115, 103331 . https://doi.org/10.1016/j.dnarep.2022.103331

The proto-oncogene BCL-3 is upregulated in a subset of colorectal cancers (CRC), where it has been shown to enhance tumour cell survival. However, although increased expression correlates with poor patient prognosis, the role of BCL-3 in determining

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5b79364554502afec628f6dd8f54280

Zobrazit plný text záznamu

Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy

Publikováno v: Terbuch, Angelika; Posch, Florian; Bauernhofer, Thomas; Jost, Philipp Jakob; Partl, Richard; Stranzl-Lawatsch, Heidi; Baciarello, Giulia; Fizazi, Karim; Giannatempo, Patrizia; Verzoni, Elena; Sweeney, Christopher; Ravi, Praful; Tran, Ben; Basso, Umberto; White, Jeff; Vincenzi, Bruno; Oing, Christoph; Cutuli, Hernan Javier; Dieckmann, Klaus Peter; Gamulin, Marija; ... (2022). Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy. International journal of radiation oncology, biology, physics, 113(4), pp. 825-832. Elsevier 10.1016/j.ijrobp.2022.03.021

Purpose: Radiation therapy is a possible treatment strategy for patients with testicular seminoma after orchiectomy in clinical stage I or II disease. Little is known about the outcome of patients who experience a relapse after radiation therapy. ---

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd5265d81573889c35449da3781137ac
https://boris.unibe.ch/169524/1/1-s2.0-S0360301622002620-main.pdf

Zobrazit plný text záznamu

Clinical recommendations for diagnosis, treatment and monitoring of patients with bladder cancer

Autor: Jazvić, Marijana, Ružić, Boris, Krušlin, Božo, Šitum, Marijan, Pešutić Piasc, Valdi, Omrčen, Tomislav, Boraska Jelavić, Tihana, Gamulin, Marija, Alduk, Ana Marija, Čorić, Marijana, Murgić, Jure, Mažuran, Berislav, Šitum, Kristina, Drežnjak Madunić, Maja, Miletić, Damir, Vojnović, Željko

Publikováno v: Liječnički vjesnik
Volume 141
Issue 11-12

Rak mokraćnog mjehura (RMM) jest, u skladu s podatcima hrvatskog Registra za rak iz 2015. godine, drugi prema učestalosti tumor urinarnog sustava, odmah nakon raka prostate. U 90% slučajeva radi se o urotelnom karcinomu, a razlika u preživljenju

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c374375c4a3e84cdca3d2fce7479fa7a
https://urn.nsk.hr/urn:nbn:hr:184:814351

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study

Publikováno v: British journal of cancer, vol. 94, no. 8, pp. 1099-106
British Journal of Cancer, Vol. 94, No 8 (2006) pp. 1099-106
British Journal of Cancer

The aim was to investigate the efficacy of neoadjuvant docetaxel–cisplatin and identify prognostic factors for outcome in locally advanced stage IIIA (pN2 by mediastinoscopy) non-small-cell lung cancer (NSCLC) patients. In all, 75 patients (from 90

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3dc1cf64797ae33965e63698aaee81f
https://doi.org/10.1038/sj.bjc.6603075

Zobrazit plný text záznamu

FANCD2 expression in advanced non-small-cell lung cancer and response to platinum-based chemotherapy

Autor: Johan P. de Winter, J. J. Oudejans, Paul J. van Diest, Barbara Vischioni, Giuseppe Giaccone, Simone W. Span, Miriam Ferrer, Frank A.E. Kruyt

Publikováno v: Clinical lung cancer, 6(4), 250-254. CIG MEDIA GROUP, LP

Fanconi's anemia (FA) is a genetically heterogeneous disease characterized by cancer susceptibility and hypersensitivity to cross-linking agents such as cisplatin. Recently, inactivation of the FA pathway has been proposed to contribute to genomic in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f394a1a7c257afae141250c5c94109be
https://research.rug.nl/en/publications/6e04aaab-a85d-41b1-a22e-500bf3ae50d5

Zobrazit plný text záznamu

Elektronická kniha

Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy

Autor: Stephen B. Howell

Taken together the data presented in this review, and work by many other investigators, support the notion that DNA excision repair is important in a tumor cell's resistance to platinum compounds. Inhibition of this repair system by combination chemo

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání